JP2008546717A5 - - Google Patents

Download PDF

Info

Publication number
JP2008546717A5
JP2008546717A5 JP2008517221A JP2008517221A JP2008546717A5 JP 2008546717 A5 JP2008546717 A5 JP 2008546717A5 JP 2008517221 A JP2008517221 A JP 2008517221A JP 2008517221 A JP2008517221 A JP 2008517221A JP 2008546717 A5 JP2008546717 A5 JP 2008546717A5
Authority
JP
Japan
Prior art keywords
substituted
trans
aminomethyl
cyclohexanecarboxylic acid
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008517221A
Other languages
English (en)
Japanese (ja)
Other versions
JP4938771B2 (ja
JP2008546717A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/023873 external-priority patent/WO2007002013A2/en
Publication of JP2008546717A publication Critical patent/JP2008546717A/ja
Publication of JP2008546717A5 publication Critical patent/JP2008546717A5/ja
Application granted granted Critical
Publication of JP4938771B2 publication Critical patent/JP4938771B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008517221A 2005-06-20 2006-06-20 トラネキサム酸のカルバミン酸アシルオキシアルキルプロドラッグ、合成法、および使用 Expired - Fee Related JP4938771B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69262505P 2005-06-20 2005-06-20
US60/692,625 2005-06-20
PCT/US2006/023873 WO2007002013A2 (en) 2005-06-20 2006-06-20 Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use

Publications (3)

Publication Number Publication Date
JP2008546717A JP2008546717A (ja) 2008-12-25
JP2008546717A5 true JP2008546717A5 (https=) 2009-12-17
JP4938771B2 JP4938771B2 (ja) 2012-05-23

Family

ID=37460256

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008517221A Expired - Fee Related JP4938771B2 (ja) 2005-06-20 2006-06-20 トラネキサム酸のカルバミン酸アシルオキシアルキルプロドラッグ、合成法、および使用

Country Status (15)

Country Link
US (4) US7351740B2 (https=)
EP (1) EP1919859B1 (https=)
JP (1) JP4938771B2 (https=)
KR (1) KR20080022203A (https=)
CN (1) CN101253148B (https=)
AT (1) ATE469880T1 (https=)
AU (1) AU2006262386B2 (https=)
CA (1) CA2612292C (https=)
DE (1) DE602006014694D1 (https=)
ES (1) ES2345784T3 (https=)
IL (1) IL188172A (https=)
NO (1) NO20076508L (https=)
NZ (1) NZ564468A (https=)
WO (1) WO2007002013A2 (https=)
ZA (1) ZA200800311B (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090214644A1 (en) * 2003-07-31 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations with reduced adverse effects
US20050025825A1 (en) * 2003-07-31 2005-02-03 Xanodyne Pharmacal, Inc. Tranexamic acid formulations with reduced adverse effects
US20090215898A1 (en) * 2004-03-04 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US8022106B2 (en) * 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
US20050244495A1 (en) 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20050245614A1 (en) * 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US7947739B2 (en) 2004-03-04 2011-05-24 Ferring B.V. Tranexamic acid formulations
WO2007002013A2 (en) 2005-06-20 2007-01-04 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
JP5313124B2 (ja) * 2006-03-16 2013-10-09 バーテックス ファーマシューティカルズ インコーポレイテッド 立体的化合物を製造するための方法および中間体
US20090082464A1 (en) * 2007-09-07 2009-03-26 Bernd Jandeleit Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
EP2217564A1 (en) * 2007-09-07 2010-08-18 XenoPort, Inc. Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
WO2010017498A1 (en) 2008-08-07 2010-02-11 Xenoport, Inc. Methods of synthesizing n-hydroxysuccinimidyl carbonates
WO2010017504A1 (en) * 2008-08-07 2010-02-11 Xenoport, Inc. Methods of synthesizing 1-(acyloxy)-alkyl carbamate prodrugs
US20100280117A1 (en) * 2009-04-30 2010-11-04 Xanodyne Pharmaceuticals, Inc. Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
WO2011028234A1 (en) 2009-09-04 2011-03-10 Xenoport, Inc. Uses of acyloxyalkyl carbamate prodrugs of tranexamic acid
WO2011091164A1 (en) 2010-01-22 2011-07-28 Xenoport, Inc. Oral dosage forms having a high loading of a tranexamic acid prodrug
US8597683B2 (en) 2010-11-30 2013-12-03 Watson Pharmaceuticals, Inc. Modified release tranexamic acid formulation
WO2012121811A1 (en) * 2011-03-04 2012-09-13 Arstat, Inc. Treatment of excessive menstrual blood loss by intravaginal administration of low doses of antifibronlytic or hemostatic agent
DE202011110392U1 (de) 2011-04-12 2014-01-16 Arstat, Inc. Oral verabreichbare pharmazeutische Zusammensetzung zur behandlung von Menstruationsschmerzen, die von übermäßigem menstruellem Blutverlust begleitet sind
FI125336B (fi) * 2012-10-31 2015-08-31 Kone Corp Hissijärjestely
WO2015089626A1 (en) 2013-12-16 2015-06-25 The University Of British Columbia Self-fueled particles for propulsion through flowing aqueous fluids
EP3681479B1 (en) 2017-09-15 2024-01-31 Dyve Biosciences, Inc. Sodium bicarbonate for use in the treatment of gout and related disorders
WO2020074160A1 (en) 2018-10-10 2020-04-16 Curovir Ab Condensed pyrimidine or pyridazine derivatives as antiviral agents
JP2020090453A (ja) * 2018-12-05 2020-06-11 ポーラ化成工業株式会社 日焼け抑制用組成物
WO2022033202A1 (zh) * 2020-08-13 2022-02-17 南京海融医药科技股份有限公司 布洛芬酯类前药、药物组合物以及制备方法和应用
CN121248675A (zh) * 2020-12-31 2026-01-02 赛诺哈勃药业（成都）有限公司 一种纤溶酶抑制剂、其制备方法及应用
EP4134362B1 (en) 2021-06-29 2024-02-28 Nanjing Heron Pharmaceutical Science and Technology Co., Ltd. Ibuprofen ester derivative and emulsion formulation thereof

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2996431A (en) 1953-12-16 1961-08-15 Barry Richard Henry Friable tablet and process for manufacturing same
US3402240A (en) 1957-06-25 1968-09-17 Pfizer & Co C Medicinal tablet and process of making same
US3139383A (en) 1961-06-26 1964-06-30 Norton Co Encapsulated time release pellets and method for encapsulating the same
US3499925A (en) 1964-03-23 1970-03-10 Daiichi Seiyaku Co Process for the production of trans-4-aminomethylcyclohexane - 1 - carboxylic acid
GB1364672A (en) 1971-06-09 1974-08-29 Beecham Group Ltd Penicillins
US3962414A (en) 1972-04-27 1976-06-08 Alza Corporation Structured bioerodible drug delivery device
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3811444A (en) 1972-12-27 1974-05-21 Alza Corp Bioerodible ocular device
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
DE2336218C3 (de) 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
US4048222A (en) 1974-03-04 1977-09-13 Kureha Kagaku Kogyo Kabushiki Kaisha Process for preparing trans-4-aminomethyl-cyclohexane-1-carboxylic acid
US3992518A (en) 1974-10-24 1976-11-16 G. D. Searle & Co. Method for making a microsealed delivery device
GB1478759A (en) 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4093709A (en) 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
JPS51138651A (en) 1975-05-27 1976-11-30 Kureha Chem Ind Co Ltd Process for pr eparing trans-4-aminomethyo-cyclohexane
US4055580A (en) 1975-08-22 1977-10-25 Rorer Italiana S.P.A. Derivatives of aminomethylcyclohexanecarboxylic acid
US4063064A (en) 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4079038A (en) 1976-03-05 1978-03-14 Alza Corporation Poly(carbonates)
US4066747A (en) 1976-04-08 1978-01-03 Alza Corporation Polymeric orthoesters housing beneficial drug for controlled release therefrom
US4070347A (en) 1976-08-16 1978-01-24 Alza Corporation Poly(orthoester) co- and homopolymers and poly(orthocarbonate) co- and homopolymers having carbonyloxy functionality
US4200098A (en) 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4285987A (en) 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4290905A (en) 1979-12-26 1981-09-22 Kabushiki Kaisha Suwa Seikosha Ester compound
ATE12224T1 (de) 1981-11-17 1985-04-15 Kabivitrum Ab Verbindungen mit antifibrinolytischer wirksamkeit.
US4434153A (en) 1982-03-22 1984-02-28 Alza Corporation Drug delivery system comprising a reservoir containing a plurality of tiny pills
US4421736A (en) 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
US4426391A (en) 1982-09-15 1984-01-17 Merck & Co., Inc. [(Alkoxycarbonyl)oxy]alkyl esters of methyldopa
IL67445A (en) 1982-12-09 1985-11-29 Teva Pharma Ethoxycarbonyloxy ethyl esters of non-steroidal anti-inflammatory carboxylic acids
US4721613A (en) 1982-12-13 1988-01-26 Alza Corporation Delivery system comprising means for shielding a multiplicity of reservoirs in selected environment of use
US4760057A (en) 1983-06-23 1988-07-26 Merck & Co., Inc. (Acyloxyalkoxy)carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs
US4916230A (en) * 1984-07-02 1990-04-10 Merck & Co., Inc. Process for preparing novel N-(acyloxy-alkoxy)carbonyl derivatives useful as bioreversible prodrug moieties for primary and secondary amine functions in drugs
US4820523A (en) 1986-04-15 1989-04-11 Warner-Lambert Company Pharmaceutical composition
US4752470A (en) 1986-11-24 1988-06-21 Mehta Atul M Controlled release indomethacin
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
US4816263A (en) 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
US4853229A (en) 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
DE69023844T2 (de) 1989-09-06 1996-06-20 Merck & Co Inc Acyloxymethylester der Bisphonsäuren als Knochenresorptions-Inhibitoren.
GB9001405D0 (en) 1990-01-22 1990-03-21 Leo Pharm Prod Ltd New intermediates,their production and use
US5698155A (en) 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5229135A (en) 1991-11-22 1993-07-20 Prographarm Laboratories Sustained release diltiazem formulation
EP0585130B1 (en) 1992-08-27 1998-01-28 Shiseido Company Limited External preparation for skin containing a depigmentation agent
SE9300013L (sv) 1992-12-30 1994-07-01 Kabi Pharmacia Ab Nytt förfarande och mellanprodukter för framställning av pro- läkemedel
JPH07165555A (ja) 1993-12-09 1995-06-27 Shiseido Co Ltd 皮膚外用剤
US5466811A (en) 1994-07-18 1995-11-14 Merck & Co., Inc. Dioxolenylmethyl carbamates pro moieties for amine drugs
US5684018A (en) 1994-12-13 1997-11-04 Merck & Co., Inc. Acyloxyisopropyl carbamates as prodrugs for amine drugs
DE69531957T2 (de) 1994-12-19 2004-08-12 Daiichi Pharmaceutical Co., Ltd. Granulat-präparate mit kontinuierlicher freisetzung und verfahren zur herstellung
JP3483988B2 (ja) 1995-06-01 2004-01-06 株式会社資生堂 皮膚外用剤
JP3814881B2 (ja) 1996-08-07 2006-08-30 味の素株式会社 シクロヘキシルアミノ酸類の製造方法
US6375987B1 (en) 1996-10-01 2002-04-23 Gattefossé, S.A. Process for the manufacture of pharmaceutical composition with modified release of active principle comprising the matrix
FR2779651B1 (fr) 1998-06-16 2001-04-20 Gattefosse Ets Sa Procede pour la fabrication de comprimes a liberation prolongee de principe(s) actif(s) presentant une cinetique de dissolution d'ordre zero
US6171615B1 (en) 1998-07-06 2001-01-09 Gattefoss{acute over (e)} Sustained release theophylline formulations, excipient systems and methods of production
WO2001005813A1 (en) 1999-07-15 2001-01-25 Eli Lilly And Company Pseudomycin prodrugs
US6627223B2 (en) 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
US6818787B2 (en) * 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
ATE540678T1 (de) * 2001-06-11 2012-01-15 Xenoport Inc Prodrugs aus gaba-analoga, zusammensetzungen und ihre verwendungen
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
WO2003077902A1 (en) 2002-02-19 2003-09-25 Xenoport, Inc. Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
ITMI20030882A1 (it) 2003-04-30 2004-11-01 Eni Spa Metodo per inibire l'acidificazione biologica di acque in contatto con materiali contenenti zolfo
WO2005010011A2 (en) 2003-07-15 2005-02-03 Xenoport, Inc. Methods of synthesis of acyloxyalkyl compounds
US7860074B2 (en) * 2003-07-31 2010-12-28 Motorola, Inc. Method and apparatus for allocating communication resources
KR20110097942A (ko) * 2003-08-20 2011-08-31 제노포트 인코포레이티드 아실옥시알킬 카르바메이트 프로드러그, 합성 및 사용 방법
PT1677767E (pt) 2003-10-14 2011-10-13 Xenoport Inc Forma cristalina de análogo de ácido gama-aminobutírico
EP2371815A1 (en) 2003-12-30 2011-10-05 XenoPort, Inc. Sythesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
US20050244495A1 (en) 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
CA2584338C (en) 2004-11-04 2013-08-06 Xenoport, Inc. Gabapentin prodrug sustained release oral dosage forms
WO2007002013A2 (en) 2005-06-20 2007-01-04 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
US7332924B2 (en) 2005-11-15 2008-02-19 Agere Systems, Inc. Embedded test circuitry and a method for testing a semiconductor device for breakdown, wearout or failure
US7770070B2 (en) * 2007-06-21 2010-08-03 Xerox Corporation Test automation via RFID technology
WO2010017498A1 (en) 2008-08-07 2010-02-11 Xenoport, Inc. Methods of synthesizing n-hydroxysuccinimidyl carbonates
WO2010017504A1 (en) 2008-08-07 2010-02-11 Xenoport, Inc. Methods of synthesizing 1-(acyloxy)-alkyl carbamate prodrugs
CN102186804A (zh) 2008-10-20 2011-09-14 克塞诺波特公司 合成左旋多巴酯前药的方法
AU2010221167B2 (en) 2009-03-06 2014-04-03 Xenoport, Inc. Oral dosage forms having a high loading of a gabapentin prodrug

Similar Documents

Publication Publication Date Title
JP2008546717A5 (https=)
AU2019213454B2 (en) 7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto
JP7013245B2 (ja) トレプロスチニル誘導体ならびにその組成物および使用
JP2003534312A (ja) 薬剤として有用な環状アミノ酸誘導体
JP6830991B2 (ja) 緑内障および高眼圧症を治療するためのプロスタグランジン複合体および誘導体
CN1269784A (zh) 用作fp激活剂的芳香族c16－c20－取代四氢前列腺素
TW202114985A (zh) Ｅｐ拮抗劑
JP5477974B2 (ja) キノリン類化合物及びその医薬組成物、製造方法並びに使用
JP7338711B2 (ja) Ｄｐアンタゴニスト
EP2669280B1 (en) Bicyclic compound and use thereof for medical purposes
JP2011515406A (ja) 治療用の置換シクロペンタン類
WO2020033960A1 (en) Substituted Dihydroxyflavone Derivatives, Compositions, and Methods Related Thereto
EP3154956A1 (en) Glucagon antagonists
AU2018210393A1 (en) Inhibitors of the N-terminal domain of the androgen receptor
CN1111407C (zh) 抗癌组合物
JP2019535795A (ja) 口腔感染症の処置のための組成物及び方法
JP6363192B2 (ja) トリグリセリド、総コレステロール、及び低密度リポタンパク質の血中濃度を低減する方法
US9751825B2 (en) TAK1 kinase inhibitors, compositions, and used related thereto
JP6698669B2 (ja) 粘膜炎の治療のための組成物及び方法
US12049474B2 (en) Nucleoside prodrugs and uses related thereto
JPWO2021041392A5 (https=)
CA2752156A1 (en) 4-(1-(3-(hydroxymethyl)-2-methylphenyl)ethyl)-1h-imidazole-2(3h)-thione
HK1259816A1 (en) 7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto
JP2013526513A (ja) ４，６−ジベンジルアミン−２−メチル−ピリミジン誘導体、および癌治療のためのそれらの使用